An NIH-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants.

A (NIH)-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants at the University of Maryland School of Medicine, Baltimore.

Researchers helped conduct an important new global health study that found a vaccine that protects against five strains of meningitis prevalent in sub-Saharan Africa is safe and effective for use in ...

A new study led by Cornell University researchers warns that habitat loss and changes in bat diets can significantly increase ...

Ensuring access to quality health care, clean air, and safe learning environments is essential for managing these conditions. However, recent administrative and legislative developments put people ...

Researchers at the National Institutes of Health (NIH) have determined that dermatitis resulting from topical steroid withdrawal (TSW) is distinct from eczema and is caused by an excess of an ...

A Democratic member of Congress has emerged as a vocal defender of the status quo at the National Institutes of ...

The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency virus (HIV), a discovery that brings medical experts one step closer to a cure ...

The German government for years concealed an assessment by its Foreign Intelligence Service that a lab origin of COVID-19 was ...

Vaccine hesitancy and higher rates of school vaccine exemptions increases the risk of outbreaks of preventable diseases, creating a significant health risk for vulnerable populations.